Zantac Remains Off Of Store Shelves More Than A Year After NDMA Contamination Was Discovered
Little is know for sure as to why ranitidine develops high levels of NDMA, a known carcinogen
Tuesday, March 2, 2021 - Over 15 million Americans were taking Zantac regularly in April 2020, when the US Food and Drug Administration (FDA) banned the drug due to accusations that ranitidine was inherently unstable and deteriorated into a carcinogenic substance. Loyal customers were left without their preferred brand of antacid and were forced to look for alternatives after the FDA recalled all forms of ranitidine and prohibited their sale over the counter and by prescription. The FDA recommended former Zantac users consider protein pump inhibitor (PPI) class antacids to replace Zantac. According to drug watch.com, "FDA recommended alternatives to Zantac (ranitidine) include: Prilosec (omeprazole), Nexium (esomeprazole), Prevacid (lansoprazole), Pepcid (famotidine) and Tagamet (cimetidine)." Also, heartburn sufferers are choosing a quick fix to their indigestion by purchasing fast-acting, over-the-counter Maalox, Mylanta, Rolaids, and Tums. Iherb.com tells readers that baking soda can help neutralize acids that are rising out of the stomach. "Baking soda, or sodium bicarbonate, has a pH level of 7.0, making it a basic substance. Its high pH can neutralize the stomach acid in the esophagus that is causing heartburn," according to IH. Mixing a little baking soda into a glass of warm water and drinking it can temporarily alleviate heartburn."
People with severe, chronic pain caused by gastrointestinal disease (GERD) are getting their prescriptions filled online by Valisure.com. The pharmacists and scientists at Valisure test prescription drugs for purity, freshness, and safety and issue customers a certificate when dispensing medicine. Valisure was the first to test Zantac for contaminates and found levels of carcinogenic NDMA thousands of times greater than the 96 NGS allowed by the FDA. The company immediately notified Sanofi, the maker of Zantac, and the company did the responsible thing and voluntarily pulled their product off the market. More than a year later, Zantac remains off of store shelving. Zantac cancer lawsuits against Sanofi, the makers of Zantac, for failing to warn consumers of the cancer risks of taking the medicine have been filed. Many accuse Zantac of causing stomach, bladder, esophagus, colon, prostate, and breast cancer. Plaintiffs allege Sanofi knew or had a responsibility to know that ranitidine was unstable and could deteriorate under certain conditions.
Zantac became the best-selling anti-heartburn and acid reflux medicine due to lifestyle and diet factors that can cause the condition. Excessive leisure habits, living a sedentary lifestyle, eating meat and sugar-based diet, being overweight, and performing a high-stress job all have a detrimental effect on the digestive system and can cause excess stomach acid production. Of all of these, overeating can be the leading cause of heartburn and acid indigestion because a full stomach can prevent the esophageal sphincter from completely closing which could allow stomach acid to travel up to the esophagus and burn the delicate tissues. It is logical to recommend that the first thing that a person should do when heartburn indigestion pain occurs is to stand up.
More Recent Heartburn MedicineLawsuit News:
- Zantac Cancer Victims Should Start Gathering Their Medical Records | 4/14/2021
- Sanofi and GSK May Have Known Ranitidine Degrades And Covered It Up | 4/13/2021
- Heartburn May Be The Body's Way of Saying You Are Eating Too Much Of The Wrong Food | 4/12/2021
- Zantac Cancer Litigation Moving Forward | 4/8/2021
- Sanofi and GalaxoSmithKline May Have Known Zantac Could Cause Cancer | 4/6/2021
- Millions of Americans Are At Risk For Zantac Cancer | 4/2/2021
- Zantac (Ranitidine) May Cause Nitrates Found In The Stomach To Become More Carcinogenic | 4/1/2021
- Zantac Plaintiffs Could Number In The Thousands Eventually | 3/31/2021
- Zantac Could Be Responsible For The Obesity Epidemic | 3/28/2021
- Zantac Cancer Lawsuits By The Loved Ones of Those Who Have Died From Cancer | 3/24/2021
- Zantac Cancer Settlement Offer Possibilities | 3/23/2021
- Heartburn Sufferers Are Patiently Awaiting Zantac Cancer Trials | 3/22/2021
- The Zantac Cancer Scare Indicates A Need For Prescription Testing | 3/18/2021
- Avoid Fried Foods And Dairy Products If You Suffer From Heartburn And Indigestion | 3/17/2021
- The World Looks To Scientific Studies To Explain Zantac's NDMA Contamination | 3/16/2021
- Juries May Have To Decide If Zantac Causes Cancer | 3/15/2021
- Former Zantac Users Warned PPI Drugs May Be Deadly Also | 3/12/2021
- Overexposure to NDMA Can Lead to Serious Health Problems | 3/10/2021
- The FDA Suspects Zantac Could Contain Five More Cancer-Causing Impurities | 3/6/2021
- The Department of Justice Points To a 1983 Study That Found Accelerated Levels of NDMA in ranitidine | 3/3/2021
- Vitamins Can Help Regulate Stomach Acid | 2/27/2021
- Online Pharmacy Can Fill Prescriptions After Testing Your Drugs For Purity and Safety | 2/22/2021
- Walmart And CVS Are Co-Defendants in Ranitidine (Zantac) Cancer Lawsuits | 2/17/2021
- More Ways To Alleviate Heartburn Pain With Zantac No Longer Available | 2/16/2021
- Gradual Lifestyle Changes Can Cure Heartburn And Acid Reflux Disease | 2/15/2021
Lawyers for Zantac Heartburn Medicine Lawsuits
OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.